20 July 2017Americas

Merck to pay Gilead $14m in attorneys’ fees

A California district court has awarded Gilead Sciences $13.8 million in attorneys’ fees in a patent dispute against Merck & Co, Merck Sharp & Dohme and Isis Pharmaceuticals.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Gilead v Merck hepatitis C dispute rocked by new allegation

3 May 2016 A judge assessing a patent dispute between Merck and Gilead centring on hepatitis C treatments has allowed Gilead to submit new evidence of jurors allegedly being misled.

Americas

Judge overturns $200m award in Gilead v Merck

9 June 2016 A US court has overturned an earlier ruling in which Merck was awarded $200 million in damages for patent infringement after finding that the pharmaceutical company had engaged in misconduct.

More on this story

Americas

Gilead v Merck hepatitis C dispute rocked by new allegation

3 May 2016 A judge assessing a patent dispute between Merck and Gilead centring on hepatitis C treatments has allowed Gilead to submit new evidence of jurors allegedly being misled.

Americas

Judge overturns $200m award in Gilead v Merck

More on this story

Americas

Gilead v Merck hepatitis C dispute rocked by new allegation

3 May 2016 A judge assessing a patent dispute between Merck and Gilead centring on hepatitis C treatments has allowed Gilead to submit new evidence of jurors allegedly being misled.

Americas

Judge overturns $200m award in Gilead v Merck